Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

MyRIAD Study

Clinical Trial Title: 
MyRIAD study.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Sarah Song, MD, MPH
Clinical Trial Protocol Description: 

The purpose of this study is to learn about the possible causes of stroke or TIA in individuals that have a narrowed brain artery.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have stroke symptoms lasting over 24 hours or transient ischemic attack (TIA).
  • Have atherosclerosis of intracranial arteries.
  • Are at least 30 years old.

You will be excluded from the study if any of the following criteria apply to you:

  • Have an allergy to gadolinium (MRI contrast).
  • Have had angioplasty/stent preformed or planned on targeted vessel.
  • Have other cause of stroke (non-atherosclerotic).
  • Have any contraindications for MRI.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Stroke and Cerebrovascular Disease
Contact Phone: 
(312) 563-2208
Contact Name: 
Tiffany Singson